Form 4: Cross Country Healthcare Executive Susan E. Ball Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Susan E. Ball, General Counsel and Secretary of Cross Country Healthcare, reports acquisition and disposal of common stock related to vesting of restricted shares and tax obligations.
Summary
- On March 31, 2024, Susan E. Ball, General Counsel and Secretary of Cross Country Healthcare, reported changes in her beneficial ownership of the company's common stock.
- She acquired 15,358 shares of common stock through vesting of restricted shares.
- She disposed of 4,788 shares, 2,934 shares, 1,740 shares and 1,690 shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock.
- The price for the disposed shares was $18.72.
- Following these transactions, Ball beneficially owns 175,400 shares of Cross Country Healthcare common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment about the company's performance.
Positives
- The vesting of restricted shares indicates that performance milestones were likely met, which is a positive signal.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the vesting of restricted stock and the subsequent sale of shares to cover tax obligations, which is a common practice.
Comparison to Industry Standards
- Form 4 filings are standard practice across all publicly listed companies and are mandated by the SEC to ensure transparency.
- The vesting schedule of the restricted shares (three substantially equal installments) is a common vesting structure.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction (acquisition and disposal of shares). |
| 03/31/2025 | First vesting date for the restricted shares. |
| 03/31/2026 | Second vesting date for the restricted shares. |
| 03/31/2027 | Third vesting date for the restricted shares. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.